• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过计算方法研究典型非洲药用植物中五种活性化合物对新型冠状病毒主要蛋白酶的治疗能力。

Therapeutic capability of five active compounds in typical African medicinal plants against main proteases of SARS-CoV-2 by computational approach.

作者信息

Abodunrin Oluwasayo Peter, Onifade Olayinka Fisayo, Adegboyega Abayomi Emmanuel

机构信息

Radiation and Health Physics, Physical Sciences Department, Bells University of Technology, Ota, Nigeria.

Phytomedicine, Biochemistry and Bioinformatics, Chemical Sciences Department, Bells University of Technology, Ota, Nigeria.

出版信息

Inform Med Unlocked. 2022;31:100964. doi: 10.1016/j.imu.2022.100964. Epub 2022 May 23.

DOI:10.1016/j.imu.2022.100964
PMID:35647264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9125996/
Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a pandemic cause of Corona Virus Disease (COVID-19), that has claimed numerous human lives across the globe. Main protease being the active protein of SARS-CoV-2 requires urgent mitigating effect against the spread of the virus. The therapeutic roles of the active compounds present in ten typical African medicinal plants were investigated in this study. Five active compounds (Curcumin and Bisdethoxy curcumin), Garcinia kola (kolaviron), (Gingerol) and a (Artemisinin) were selected and docked against Main protease through receptor grid generation, protein ligand docking, receptor ligand complex pharmacophore and binding free energy. The results obtained revealed Curcumin had the highest binding score of -8.628 kcal/mol while artermisinin presented the least with -4.123 kcal/mol. The outcome of the pharmacokinetic prediction in this study revealed high transport capacity across the gastrointestinal tract and high blood brain barrier permeability for curcumin, bisdemethoxy curcumin, gingerol and artemisinin. The exemption is gingerol with low LD value (250 mg/kg), the LD of all active compounds ranged from 2000 to 4228 mg/kg. Adsorption, distribution, metabolism, excretion and toxicity (ADMET) properties exhibited by all compounds portrayed them as non-hepatotoxic, non-cytotoxic, non-mutagenic and non-carcinogenic. The active compounds exhibited drug-likeness features against Main protease of Covid-19.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是冠状病毒病(COVID-19)的大流行病因,已在全球夺走了无数人的生命。主要蛋白酶作为SARS-CoV-2的活性蛋白,需要对病毒传播产生紧急缓解作用。本研究调查了十种典型非洲药用植物中活性化合物的治疗作用。选择了五种活性化合物(姜黄素和双去甲氧基姜黄素)、可乐果(可乐维酮)、(姜辣素)和一种(青蒿素),通过受体网格生成、蛋白质配体对接、受体配体复合物药效团和结合自由能,将它们与主要蛋白酶进行对接。所得结果显示,姜黄素的结合得分最高,为-8.628千卡/摩尔,而青蒿素的结合得分最低,为-4.123千卡/摩尔。本研究的药代动力学预测结果显示,姜黄素、双去甲氧基姜黄素、姜辣素和青蒿素在胃肠道具有较高的转运能力,且血脑屏障通透性较高。例外的是姜辣素,其LD值较低(250毫克/千克),所有活性化合物的LD值范围为2000至4228毫克/千克。所有化合物表现出的吸收、分布、代谢、排泄和毒性(ADMET)特性表明它们无肝毒性、无细胞毒性、无致突变性和无致癌性。这些活性化合物对COVID-19的主要蛋白酶表现出类药物特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/b85ef9417b08/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/4b3472d30d54/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/de65d20b7e8c/gr2a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/5d666c5208d9/gr2b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/bbe74e4838ea/gr2c_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/ab283a10824f/gr2d_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/2e039fea88b6/gr2e_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/e18140fec5ca/gr2f_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/98403095b2c4/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/b85ef9417b08/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/4b3472d30d54/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/de65d20b7e8c/gr2a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/5d666c5208d9/gr2b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/bbe74e4838ea/gr2c_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/ab283a10824f/gr2d_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/2e039fea88b6/gr2e_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/e18140fec5ca/gr2f_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/98403095b2c4/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9699/9125996/b85ef9417b08/gr4_lrg.jpg

相似文献

1
Therapeutic capability of five active compounds in typical African medicinal plants against main proteases of SARS-CoV-2 by computational approach.通过计算方法研究典型非洲药用植物中五种活性化合物对新型冠状病毒主要蛋白酶的治疗能力。
Inform Med Unlocked. 2022;31:100964. doi: 10.1016/j.imu.2022.100964. Epub 2022 May 23.
2
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.通过阿育吠陀药用植物( Ashwagandha )、( Giloy )和( Tulsi )的活性植物化学成分靶向 COVID-19 ( SARS-CoV-2 )主蛋白酶 - ( Ashwagandha )、( Giloy )和( Tulsi ) - 分子对接研究。
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
3
Virtual Screening of Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme.基于 SARS-CoV-2 主蛋白酶的虚拟筛选潜在抑制剂的植物化学成分
Molecules. 2022 Nov 21;27(22):8103. doi: 10.3390/molecules27228103.
4
Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection.对三种药用植物中的植物化学物质进行计算筛选,以寻找作为跨膜蛋白酶丝氨酸2抑制剂的物质,该蛋白酶与SARS-CoV-2感染有关。
Phytomed Plus. 2021 Nov;1(4):100135. doi: 10.1016/j.phyplu.2021.100135. Epub 2021 Sep 29.
5
validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.验证香豆素衍生物作为潜在抑制剂对 SARS-CoV-2 的主要蛋白酶、NSP10/NSP16-甲基转移酶、磷酸酶和内切核糖核酸酶的抑制作用。
J Biomol Struct Dyn. 2021 Nov;39(18):7306-7321. doi: 10.1080/07391102.2020.1808075. Epub 2020 Aug 24.
6
Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies.通过分子对接、分子动力学和 MM-PBSA 研究揭示的源自 Ayurvedic 药用植物的活性成分对 SARS-CoV-2 相关靶蛋白的再利用潜力。
Biomed Pharmacother. 2021 May;137:111356. doi: 10.1016/j.biopha.2021.111356. Epub 2021 Feb 3.
7
Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: identification.来自药用植物的针对严重急性呼吸综合征冠状病毒2主要蛋白酶的有前景的抑制剂:鉴定
Acta Pharm. 2021 Dec 30;72(2):159-169. doi: 10.2478/acph-2022-0020. Print 2022 Jun 1.
8
Docking Analysis of Some Bioactive Compounds from Traditional Plants against SARS-CoV-2 Target Proteins.从传统植物中提取的一些具有生物活性的化合物对 SARS-CoV-2 靶蛋白的对接分析。
Molecules. 2022 Apr 20;27(9):2662. doi: 10.3390/molecules27092662.
9
Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases.基于蒜素、姜黄素和姜辣素的药物信息学及假设性研究,探讨其作为抗 COVID-19 相关蛋白酶的潜在候选药物。
J Biomol Struct Dyn. 2022 Jan;40(1):389-400. doi: 10.1080/07391102.2020.1813630. Epub 2020 Sep 2.
10
Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics.从药用植物中生物导向分离严重急性呼吸综合征冠状病毒2主蛋白酶抑制剂:体外测定和分子动力学
Plants (Basel). 2022 Jul 24;11(15):1914. doi: 10.3390/plants11151914.

引用本文的文献

1
Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive Review.用草药治疗 COVID-19:这是否可行?一篇全面的综述。
Viruses. 2024 Feb 20;16(3):320. doi: 10.3390/v16030320.
2
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products.通过天然产物对抗 COVID-19:药物化学家的各种尝试的全面更新。
Molecules. 2023 Jun 20;28(12):4860. doi: 10.3390/molecules28124860.

本文引用的文献

1
SARS-CoV-2 aerosol generation during respiratory equipment reprocessing.新冠病毒在呼吸设备再处理过程中的气溶胶生成。
Antimicrob Resist Infect Control. 2021 May 27;10(1):82. doi: 10.1186/s13756-021-00955-2.
2
SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome.人类代谢组中 SARS-CoV-2 主蛋白酶活性位点配体。
Molecules. 2021 Mar 5;26(5):1409. doi: 10.3390/molecules26051409.
3
Benzo[a]pyrene and Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide induced locomotor and reproductive senescence and altered biochemical parameters of oxidative damage in Canton-S .
苯并[a]芘和苯并[a]芘-7,8-二氢二醇-9,10-环氧化物诱导了运动和生殖衰老,并改变了Canton-S品系果蝇的氧化损伤生化参数。
Toxicol Rep. 2021 Mar 10;8:571-580. doi: 10.1016/j.toxrep.2021.03.001. eCollection 2021.
4
Kolaviron: A Biflavonoid with Numerous Health Benefits.科拉维酮:具有多种健康益处的双黄酮类化合物。
Curr Pharm Des. 2021;27(4):490-504. doi: 10.2174/1381612826666201113094303.
5
Repurposing Antimalarials to Tackle the COVID-19 Pandemic.抗疟疾药物再利用以应对 COVID-19 大流行。
Trends Parasitol. 2021 Jan;37(1):8-11. doi: 10.1016/j.pt.2020.10.003. Epub 2020 Oct 19.
6
Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial.青蒿琥酯-哌喹治疗 COVID-19 的安全性和有效性:一项开放标签、非随机对照试验。
Int J Antimicrob Agents. 2021 Jan;57(1):106216. doi: 10.1016/j.ijantimicag.2020.106216. Epub 2020 Nov 2.
7
Biochemical screening for SARS-CoV-2 main protease inhibitors.针对 SARS-CoV-2 主蛋白酶抑制剂的生化筛选。
PLoS One. 2020 Oct 6;15(10):e0240079. doi: 10.1371/journal.pone.0240079. eCollection 2020.
8
Discovery of Traditional Chinese Medicine Derived Compounds as Wild Type and Mutant Plasmodium falciparum Dihydrofolate Reductase Inhibitors: Induced Fit Docking and ADME Studies.发现中药衍生化合物作为野生型和突变型疟原虫二氢叶酸还原酶抑制剂:诱导契合对接和 ADME 研究。
Curr Drug Discov Technol. 2021;18(4):554-569. doi: 10.2174/1570163817999200729122753.
9
The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options.SARS-CoV-2 分子生物学与发病机制的新视角及治疗选择。
DNA Cell Biol. 2020 Oct;39(10):1741-1753. doi: 10.1089/dna.2020.5703. Epub 2020 Jul 21.
10
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor.基于结构的药物设计,用于研究阿育吠陀中选定天然产物对SARS-CoV-2刺突糖蛋白及其细胞受体的潜在抗病毒活性。
Virusdisease. 2020 Jun;31(2):179-193. doi: 10.1007/s13337-020-00598-8. Epub 2020 May 24.